Solae, LLC Report issue

For profit Phase 2 Phase 3
Founded: St Louis, MO MO United States (1958)
Status: Acquired by DuPont (2012) → now Bristol-Myers Squibb (2001)

Organization Overview

First Clinical Trial
2001
NCT00661856
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Protein Technologies International | Solae, LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

soybean (5 trials)

Drugs in Phase 2 Trials (2)

isoflavone (1 trial)

tamoxifen (nolvadex) (1 trial)

Drugs in Other Trials (5)

icosapent ethyl (vascepa) (2 trials)

soybean oil (Intralipid) (1 trial)

stearidonic acid (1 trial)

sunflower oil (1 trial)

whey protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 3)

Breast Neoplasms (Phase 2)

Cardiovascular Diseases (Phase 3)

Heart Diseases (Phase 3)

Hot Flashes (Phase 2)

Osteoporosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 8